Cargando…

Cisplatin Resistance: Genetic and Epigenetic Factors Involved

Cisplatin (CDDP) is the drug of choice against different types of cancer. However, tumor cells can acquire resistance to the damage caused by cisplatin, generating genetic and epigenetic changes that lead to the generation of resistance and the activation of intrinsic resistance mechanisms in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugones, Yuliannis, Loren, Pía, Salazar, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599500/
https://www.ncbi.nlm.nih.gov/pubmed/36291573
http://dx.doi.org/10.3390/biom12101365

Ejemplares similares